Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.910
-0.090 (-2.25%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $151.16 million as of July 16, 2026. Its market cap has increased by 10.65% in one year.
Market Cap
151.16M
Enterprise Value
57.64M
1-Year Change
10.65%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $151.16M, a decrease of -77.88%. That is a compound annual growth rate of -25.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 151.16M | -5.60% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 160.34M |
| LENZ Therapeutics | 154.58M |
| Alector | 154.33M |
| Kazia Therapeutics | 153.92M |
| TuHURA Biosciences | 151.56M |
| YD Bio | 149.08M |
| Connect Biopharma Holdings | 148.28M |
| Pyxis Oncology | 145.08M |